A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 26, 2014

Primary Completion Date

August 12, 2016

Study Completion Date

July 13, 2017

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

E6011

Trial Locations (12)

Unknown

Kitakyushu

Sapporo

Kakogawa

Katō

Kahoku-gun

Yokohama

Hamamatsu

Chuo-Ku

Meguro-Ku

Ōta-ku

Shinjuku-Ku

Miyazaki

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02196558 - A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter